ATE429638T1 - Inhibitoren der pghs-2 transaktivator-aktivität - Google Patents
Inhibitoren der pghs-2 transaktivator-aktivitätInfo
- Publication number
- ATE429638T1 ATE429638T1 AT06770985T AT06770985T ATE429638T1 AT E429638 T1 ATE429638 T1 AT E429638T1 AT 06770985 T AT06770985 T AT 06770985T AT 06770985 T AT06770985 T AT 06770985T AT E429638 T1 ATE429638 T1 AT E429638T1
- Authority
- AT
- Austria
- Prior art keywords
- pghs
- prostaglandin
- inhibitors
- identify
- endoperoxide
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 102000010907 Cyclooxygenase 2 Human genes 0.000 title 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 title 1
- 102000040945 Transcription factor Human genes 0.000 title 1
- 108091023040 Transcription factor Proteins 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 101710186200 CCAAT/enhancer-binding protein Proteins 0.000 abstract 1
- 238000012287 DNA Binding Assay Methods 0.000 abstract 1
- 108010057466 NF-kappa B Proteins 0.000 abstract 1
- 102000003945 NF-kappa B Human genes 0.000 abstract 1
- 229940114079 arachidonic acid Drugs 0.000 abstract 1
- 235000021342 arachidonic acid Nutrition 0.000 abstract 1
- 230000027455 binding Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 101150036876 cre gene Proteins 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 abstract 1
- 229940124606 potential therapeutic agent Drugs 0.000 abstract 1
- YIBNHAJFJUQSRA-YNNPMVKQSA-N prostaglandin H2 Chemical compound C1[C@@H]2OO[C@H]1[C@H](/C=C/[C@@H](O)CCCCC)[C@H]2C\C=C/CCCC(O)=O YIBNHAJFJUQSRA-YNNPMVKQSA-N 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000002103 transcriptional effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5032—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on intercellular interactions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/90245—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68362605P | 2005-05-23 | 2005-05-23 | |
| PCT/US2006/019965 WO2006127731A2 (en) | 2005-05-23 | 2006-05-23 | Inhibitors of pghs-2transactivator activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE429638T1 true ATE429638T1 (de) | 2009-05-15 |
Family
ID=37452754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06770985T ATE429638T1 (de) | 2005-05-23 | 2006-05-23 | Inhibitoren der pghs-2 transaktivator-aktivität |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7927799B2 (de) |
| EP (1) | EP1889057B1 (de) |
| JP (1) | JP2009506754A (de) |
| AT (1) | ATE429638T1 (de) |
| AU (1) | AU2006250294B9 (de) |
| CA (1) | CA2609495A1 (de) |
| DE (1) | DE602006006441D1 (de) |
| ES (1) | ES2328406T3 (de) |
| WO (1) | WO2006127731A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006250294B9 (en) * | 2005-05-23 | 2011-10-27 | Ordway Research Institute, Inc. | Inhibitors of PGHS-2 transactivator activity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6200760B1 (en) * | 1997-02-24 | 2001-03-13 | Cornell Research Foundation, Inc. | Method of screening agents as candidates for drugs or sources of drugs |
| ES2160062B1 (es) * | 1999-07-12 | 2002-05-16 | Esteve Labor Dr | Linea celular que comprende el promotor de la ciclooxigenasa-2 (cox-2) y un gen testigo y su empleo en la busqueda de inhibidores selectivos de la induccion transcripcional de cox-2. |
| AU2006250294B9 (en) * | 2005-05-23 | 2011-10-27 | Ordway Research Institute, Inc. | Inhibitors of PGHS-2 transactivator activity |
-
2006
- 2006-05-23 AU AU2006250294A patent/AU2006250294B9/en not_active Ceased
- 2006-05-23 DE DE602006006441T patent/DE602006006441D1/de active Active
- 2006-05-23 CA CA002609495A patent/CA2609495A1/en not_active Abandoned
- 2006-05-23 EP EP06770985A patent/EP1889057B1/de not_active Expired - Lifetime
- 2006-05-23 WO PCT/US2006/019965 patent/WO2006127731A2/en not_active Ceased
- 2006-05-23 JP JP2008513636A patent/JP2009506754A/ja active Pending
- 2006-05-23 ES ES06770985T patent/ES2328406T3/es not_active Expired - Lifetime
- 2006-05-23 US US11/920,910 patent/US7927799B2/en not_active Expired - Fee Related
- 2006-05-23 AT AT06770985T patent/ATE429638T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1889057B1 (de) | 2009-04-22 |
| EP1889057A2 (de) | 2008-02-20 |
| JP2009506754A (ja) | 2009-02-19 |
| US7927799B2 (en) | 2011-04-19 |
| US20090298058A1 (en) | 2009-12-03 |
| AU2006250294A1 (en) | 2006-11-30 |
| CA2609495A1 (en) | 2006-11-30 |
| WO2006127731A3 (en) | 2007-08-30 |
| AU2006250294B2 (en) | 2011-08-04 |
| AU2006250294B9 (en) | 2011-10-27 |
| DE602006006441D1 (de) | 2009-06-04 |
| WO2006127731A2 (en) | 2006-11-30 |
| ES2328406T3 (es) | 2009-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang | Transcriptional regulation by histone ubiquitination and deubiquitination | |
| Page et al. | Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape | |
| Hofer et al. | Detection, structure and function of modified DNA bases | |
| Storey | Evidence for a reduced transcriptional state during hibernation in ground squirrels | |
| Bianchi et al. | Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants | |
| EP2021534A4 (de) | Abschätzung und verringerung des risikos von graft-versus-host-reaktion | |
| Gui et al. | Substrate-induced control of product formation by protein arginine methyltransferase 1 | |
| EP2543389A3 (de) | Verfahren und Zusammensetzungen zur Behandlung und Diagnose von Fibrose, Tumorinvasion, Angiogenese und Metastasen | |
| WO2007041201A3 (en) | Compositions, methods, and kits for amplifying nucleic acids | |
| WO2009021031A3 (en) | Proximity ligation assay | |
| Krzywonos‐Zawadzka et al. | Cardioprotective effect of MMP‐2‐inhibitor‐NO‐donor hybrid against ischaemia/reperfusion injury | |
| MX344371B (es) | Amplificacion de señal. | |
| ATE373715T1 (de) | Isoprenoid biosynthese | |
| ATE505562T1 (de) | Doppel-oligonukleotid- nukleinsäurenachweisverfahren | |
| Alpoim-Moreira et al. | Metallopeptidades 2 and 9 genes epigenetically modulate equine endometrial fibrosis | |
| MX2008013397A (es) | Analisis de perfilamiento de expresion diferencial de fenotipos de cultivo celular y usos de los mismos. | |
| ATE448189T1 (de) | Glycerin-peg-derivate als inhibitoren der cyclooxigenase-2 und der phospholipase-a2 | |
| Arun et al. | Zoledronate upregulates MMP-9 and-13 in rat vascular smooth muscle cells by inducing oxidative stress | |
| Tsai et al. | Suppression of ornithine decarboxylase promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells | |
| Jennings et al. | Analogs of farnesyl diphosphate alter CaaX substrate specificity and reactions rates of protein farnesyltransferase | |
| DE602006006441D1 (de) | Inhibitoren der pghs-2 transaktivator-aktivität | |
| Higashi et al. | Core histone H2A ubiquitylation and transcriptional regulation | |
| Suzuki et al. | The histone deacetylase inhibitor MS-275 enhances the matrix mineralization of dental pulp stem cells by inducing fibronectin expression | |
| FR2875240B1 (fr) | Procede de detection de streptococcus agalactiae en utilisant l'activite alpha-glucosidase | |
| Cheng et al. | The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |